Sana Biotechnology (SANA) Non-Current Assets (2020 - 2026)

Sana Biotechnology's Non-Current Assets history runs 7 years deep, the most recent figure standing at $261.9 million for Q1 2026.

• In Q1 2026, Non-Current Assets fell 21.29% year-over-year to $261.9 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 21.38% YoY), while the FY2025 annual figure was $268.2 million, down 21.16% from the prior year.
• Non-Current Assets came in at $261.9 million for Q1 2026 at Sana Biotechnology, down from $268.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $524.4 million in Q1 2022 to a low of $261.9 million in Q1 2026.
• A 5-year average of $355.7 million and a median of $351.9 million in 2023 frame the typical range for Non-Current Assets.
• On a YoY basis, Non-Current Assets climbed as much as 55.61% in 2022 and fell as far as 35.82% in 2022.
• Sana Biotechnology's Non-Current Assets stood at $378.3 million in 2022, then retreated by 7.01% to $351.8 million in 2023, then retreated by 3.29% to $340.2 million in 2024, then declined by 21.16% to $268.2 million in 2025, then retreated by 2.35% to $261.9 million in 2026.
• According to Business Quant data, Non-Current Assets over the past three periods registered $261.9 million, $268.2 million, and $273.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison